Enterprise Value
307.6M
Cash
244.1M
Avg Qtr Burn
-19.11M
Short % of Float
3.70%
Insider Ownership
8.94%
Institutional Own.
72.62%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HIL-214 Details Norovirus | Phase 2b Data readout |